These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 35045871)

  • 1. Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation.
    Bell KJ; Saad S; Tillett BJ; McGuire HM; Bordbar S; Yap YA; Nguyen LT; Wilkins MR; Corley S; Brodie S; Duong S; Wright CJ; Twigg S; de St Groth BF; Harrison LC; Mackay CR; Gurzov EN; Hamilton-Williams EE; Mariño E
    Microbiome; 2022 Jan; 10(1):9. PubMed ID: 35045871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
    van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
    J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K2 supplementation improves impaired glycemic homeostasis and insulin sensitivity for type 2 diabetes through gut microbiome and fecal metabolites.
    Zhang Y; Liu L; Wei C; Wang X; Li R; Xu X; Zhang Y; Geng G; Dang K; Ming Z; Tao X; Xu H; Yan X; Zhang J; Hu J; Li Y
    BMC Med; 2023 May; 21(1):174. PubMed ID: 37147641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Ojo O; Feng QQ; Ojo OO; Wang XH
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
    Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
    Front Immunol; 2019; 10():1733. PubMed ID: 31417546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a high dietary intake of resistant starch affect glycaemic control and alter the gut microbiome in women with gestational diabetes? A randomised control trial protocol.
    Latino C; Gianatti EJ; Mehta S; Lo J; Devine A; Christophersen C
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):46. PubMed ID: 35042457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary SCFAs, IL-22, and GFAP: The Three Musketeers in the Gut-Neuro-Immune Network in Type 1 Diabetes.
    Jayasimhan A; Mariño E
    Front Immunol; 2019; 10():2429. PubMed ID: 31736937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes.
    Vandenbempt V; Eski SE; Brahma MK; Li A; Negueruela J; Bruggeman Y; Demine S; Xiao P; Cardozo AK; Baeyens N; Martelotto LG; Singh SP; Mariño E; Gysemans C; Gurzov EN
    iScience; 2024 Jan; 27(1):108694. PubMed ID: 38213620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis.
    Portincasa P; Bonfrate L; Vacca M; De Angelis M; Farella I; Lanza E; Khalil M; Wang DQ; Sperandio M; Di Ciaula A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbial metabolites alter IgA immunity in type 1 diabetes.
    Huang J; Pearson JA; Peng J; Hu Y; Sha S; Xing Y; Huang G; Li X; Hu F; Xie Z; Xiao Y; Luo S; Chao C; Wong FS; Zhou Z; Wen L
    JCI Insight; 2020 May; 5(10):. PubMed ID: 32298241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort.
    Yang T; Wu C; Li Y; Wang C; Mao Z; Huo W; Li J; Li Y; Xing W; Li L
    Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1619-1630. PubMed ID: 38653672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model.
    Lee JG; Lee J; Lee AR; Jo SV; Park CH; Han DS; Eun CS
    J Nutr Biochem; 2022 Mar; 101():108926. PubMed ID: 34848335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of disordered eating with the intestinal microbiota and short-chain fatty acids among young adults with type 1 diabetes.
    Igudesman D; Crandell J; Corbin KD; Zaharieva DP; Addala A; Thomas JM; Bulik CM; Pence BW; Pratley RE; Kosorok MR; Maahs DM; Carroll IM; Mayer-Davis EJ
    Nutr Metab Cardiovasc Dis; 2023 Feb; 33(2):388-398. PubMed ID: 36586772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial.
    Ismail HM; Spall M; Evans-Molina C; DiMeglio LA
    Pilot Feasibility Stud; 2023 Aug; 9(1):150. PubMed ID: 37626387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial.
    Jama HA; Rhys-Jones D; Nakai M; Yao CK; Climie RE; Sata Y; Anderson D; Creek DJ; Head GA; Kaye DM; Mackay CR; Muir J; Marques FZ
    Nat Cardiovasc Res; 2023 Jan; 2(1):35-43. PubMed ID: 39196205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riboflavin Supplementation Promotes Butyrate Production in the Absence of Gross Compositional Changes in the Gut Microbiota.
    Liu L; Sadaghian Sadabad M; Gabarrini G; Lisotto P; von Martels JZH; Wardill HR; Dijkstra G; Steinert RE; Harmsen HJM
    Antioxid Redox Signal; 2023 Feb; 38(4-6):282-297. PubMed ID: 35943883
    [No Abstract]   [Full Text] [Related]  

  • 19. A major mechanism for immunomodulation: Dietary fibres and acid metabolites.
    Xie L; Alam MJ; Marques FZ; Mackay CR
    Semin Immunol; 2023 Mar; 66():101737. PubMed ID: 36857894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adalimumab therapy is associated with increased faecal short chain fatty acids in hidradenitis suppurativa.
    Tatian A; Bordbar S; Sarkissian S; Woods JA; Cains GD; Chong CW; Mariño E; Frew JW
    Exp Dermatol; 2022 Dec; 31(12):1872-1880. PubMed ID: 36054650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.